| Lactose (India) Ltd | 138 Cr. | 110 | 231/84.3 | 30.5 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.54 Cr. | 1.85 | 4.29/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,435 Cr. | 408 | 479/192 | 91.8 | 24.3 | 0.16 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 35.2 Cr. | 47.5 | 88.6/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 49.8 Cr. | 34.0 | 34.7/17.0 | 119 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 62.1 Cr. | 82.4 | 121/69.7 | 16.8 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 57,755 Cr. | 2,047 | 2,286/1,275 | 23.0 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 307 Cr. | 12.6 | 19.0/10.8 | 18.4 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 18.0/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 810 Cr. | 1,716 | 1,999/635 | 28.0 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 91.0 Cr. | 18.2 | 32.0/17.0 | 24.9 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 1,025 Cr. | 348 | 449/219 | 9.15 | 133 | 0.72 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.36 Cr. | 20.8 | 39.0/20.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 9.51 Cr. | 3.82 | 8.28/2.11 | 5.40 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 439 Cr. | 452 | 499/211 | 66.3 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,184 Cr. | 962 | 1,565/956 | 37.8 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 59.3 Cr. | 0.29 | 1.12/0.24 | 3.90 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 43.6 Cr. | 16.6 | 26.3/7.50 | 21.3 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.59 Cr. | 9.49 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 170 Cr. | 477 | 859/431 | 9.65 | 596 | 0.31 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 83.0 Cr. | 83.0 | 92.5/26.1 | 157 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,077 Cr. | 1,344 | 2,452/1,315 | 43.8 | 174 | 0.80 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 21.7 Cr. | 47.5 | 88.7/36.1 | 47.2 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.5 Cr. | 4.99 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.8 Cr. | 112 | 152/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 56.2 Cr. | 103 | 114/9.41 | 38.8 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 34.0 Cr. | 45.0 | 80.0/33.0 | 54.8 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.63 Cr. | 22.1 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,536 Cr. | 550 | 1,028/512 | 27.1 | 72.4 | 0.22 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 91.1 Cr. | 21.1 | 35.9/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 12.2 Cr. | 24.0 | 43.7/17.4 | 52.9 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 91,986 Cr. | 2,230 | 2,998/2,090 | 55.2 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 242 Cr. | 421 | 524/241 | 24.9 | 123 | 1.07 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 49.3 Cr. | 34.3 | 58.9/26.7 | 77.0 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 70,756 Cr. | 1,218 | 1,365/994 | 20.7 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 165 Cr. | 265 | 303/159 | 157 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 788 Cr. | 78.6 | 122/74.0 | 20.4 | 32.6 | 1.91 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 37.8 Cr. | 29.0 | 46.5/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,883 Cr. | 1,695 | 1,902/919 | 62.0 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.17 Cr. | 0.63 | 1.38/0.51 | 104 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 242 Cr. | 31.6 | 60.0/26.0 | 15.5 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 5.14 Cr. | 8.78 | 22.2/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 138 Cr. | 5.85 | 6.57/2.82 | 320 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 60,138 Cr. | 28,295 | 37,000/25,260 | 39.8 | 1,888 | 1.68 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,074 Cr. | 781 | 972/557 | 29.5 | 226 | 0.64 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 205 Cr. | 72.3 | 100/31.3 | 57.2 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 5,212 Cr. | 1,571 | 1,740/752 | | 103 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 23,482 Cr. | 1,445 | 1,870/1,110 | 428 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 829 Cr. | 237 | 330/154 | 19.3 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 190 Cr. | 22.8 | 29.4/22.8 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,083 Cr. | 816 | 840/270 | 17.1 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,173 Cr. | 451 | 791/432 | 21.8 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,459 Cr. | 1,036 | 1,458/991 | 20.7 | 768 | 0.97 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,29,340 Cr. | 3,820 | 3,882/2,886 | 59.7 | 250 | 0.84 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 962 Cr. | 105 | 284/98.0 | | 41.3 | 0.48 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,394 Cr. | 14.8 | 23.5/14.1 | 22.2 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,481 Cr. | 535 | 1,328/518 | 59.6 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,889 Cr. | 171 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,20,954 Cr. | 1,756 | 1,910/1,547 | 36.5 | 324 | 0.91 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,534 Cr. | 570 | 734/441 | 395 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,956 Cr. | 315 | 335/175 | 36.4 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,333 Cr. | 324 | 502/265 | 40.9 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,503 Cr. | 217 | 260/111 | 127 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,378 Cr. | 4,071 | 6,718/4,050 | 25.4 | 340 | 2.87 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,872 Cr. | 2,353 | 2,725/1,772 | 34.7 | 335 | 0.85 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,439 Cr. | 5,670 | 6,739/4,904 | 30.8 | 373 | 2.20 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 171 Cr. | 48.4 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,196 Cr. | 5,068 | 5,993/3,701 | 32.8 | 841 | 0.69 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 129 Cr. | 105 | 220/81.0 | 13.3 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,182 Cr. | 356 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,970 Cr. | 783 | 1,998/604 | 76.0 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 19,664 Cr. | 15,327 | 19,748/10,060 | 100 | 1,263 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 499 Cr. | 22.2 | 41.4/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,603 Cr. | 927 | 1,420/660 | 10.8 | 483 | 0.65 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,316 Cr. | 42.3 | 80.7/38.4 | 30.7 | 21.8 | 0.47 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,285 Cr. | 183 | 308/162 | 23.6 | 59.3 | 0.44 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 37.8 Cr. | 24.0 | 130/23.4 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 275 Cr. | 76.4 | 167/72.2 | 135 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 96,554 Cr. | 2,114 | 2,403/1,774 | 22.3 | 430 | 0.57 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 984 Cr. | 490 | 872/464 | 12.3 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 57,722 Cr. | 1,068 | 1,073/501 | 84.5 | 91.1 | 0.11 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,171 Cr. | 1,128 | 1,235/596 | 23.8 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 153 Cr. | 69.8 | 114/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 734 Cr. | 152 | 225/123 | 41.7 | 104 | 1.97 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 611 Cr. | 350 | 500/265 | 22.2 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,222 Cr. | 1,082 | 1,250/802 | 34.6 | 414 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,261 Cr. | 1,805 | 1,918/1,303 | 39.3 | 243 | 0.86 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,345 Cr. | 202 | 302/193 | 30.7 | 38.0 | 1.24 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,459 Cr. | 1,435 | 1,758/1,168 | 36.8 | 293 | 0.28 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,461 Cr. | 83.8 | 127/57.5 | 21.2 | 59.7 | 0.95 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 756 Cr. | 92.9 | 124/67.2 | 25.5 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,187 Cr. | 237 | 350/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,987 Cr. | 242 | 457/217 | 296 | 96.9 | 0.58 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,360 Cr. | 1,593 | 2,496/1,243 | 31.0 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,460 Cr. | 346 | 498/285 | 63.7 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,916 Cr. | 615 | 621/412 | 29.2 | 164 | 0.24 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 57,755 Cr. | 2,047 | 2,286/1,275 | 23.0 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,357 Cr. | 2,500 | 3,516/1,921 | 44.4 | 101 | 1.68 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,770 Cr. | 1,688 | 2,131/1,200 | 24.0 | 610 | 1.07 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,693 Cr. | 411 | 528/359 | 29.7 | 149 | 1.22 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,110 Cr. | 1,552 | 1,910/1,097 | 50.8 | 227 | 0.47 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,07,087 Cr. | 1,284 | 1,406/1,020 | 18.6 | 432 | 0.62 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,012 Cr. | 256 | 322/178 | 26.8 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,21,254 Cr. | 1,501 | 1,673/1,310 | 22.3 | 408 | 0.87 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 15,072 Cr. | 1,981 | 2,641/1,551 | 25.6 | 416 | 0.30 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 272 Cr. | 92.7 | 203/92.0 | 19.4 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,896 Cr. | 179 | 191/105 | 17.3 | 107 | 0.28 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 54.2 Cr. | 33.1 | 63.1/32.5 | 19.0 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 53,719 Cr. | 402 | 425/291 | 113 | 200 | 0.12 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,593 Cr. | 1,578 | 2,046/1,430 | 35.2 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 117 Cr. | 73.8 | 132/70.0 | 17.2 | 49.2 | 1.63 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 390 Cr. | 165 | 205/67.8 | 36.9 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,879 Cr. | 9,140 | 10,691/6,301 | 99.0 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,978 Cr. | 682 | 843/544 | 34.9 | 118 | 0.67 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 163 Cr. | 77.2 | 137/75.0 | 8.64 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 66,978 Cr. | 5,597 | 5,868/4,492 | 28.5 | 1,116 | 0.80 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,853 Cr. | 857 | 1,124/725 | 26.6 | 271 | 1.28 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 424 Cr. | 750 | 1,412/736 | | 690 | 0.67 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,324 Cr. | 2,668 | 3,116/2,022 | 34.2 | 345 | 1.05 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,441 Cr. | 307 | 367/258 | 23.3 | 133 | 1.69 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,754 Cr. | 412 | 575/312 | 19.7 | 147 | 0.24 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,300.39 Cr | 1,155.94 | | 53.32 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |